Overall rank by patents
#1,089
of 49,997 tracked assignees
USPTO PatentsView assignee record - 391 granted patents across 73 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Shenzhen ranks #1,089 of 49,997 tracked US assignees by granted-patent volume, with 391 patents across 73 technology areas.
USPTO PatentsView assignee plate
Corpus R1089 · Foreign Corporation #1,089 · 391 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Oxford University Innovation Limited (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
CNH Industrial America · near
66 score
Shenzhen Mindray… · this assignee
66 score
Konica Minolta… · near
66 score
THE Johns Hopkins… · near
66 score
China Petroleum &… · near
66 score
3D Lighting… · lowest
7 score
What this shows Shenzhen's Innovation Score is 66.3/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Between 2020–2024, Shenzhen Mindray Bio-medical Electronics Co., Ltd. received 227 grants versus 131 in 2015–2019 (+73% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2024 at 58 grants and bottomed in 2016 at 21. Lead class A61B accounts for 58.8% of the portfolio across 73 subclasses. Volume neighbours: CommScope Connectivity Belgium Bvba (#1,085) and Allison Transmission, Inc. (#1,093).
From 2019–2021 to 2022–2024, Shenzhen Mindray Bio-medical Electronics Co., Ltd. moved from 95 to 154 grants (1.62x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #361. See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
CommScope Connectivity Belgium Bvba
392 patents
Fujitsu Component Limited
392 patents
Stats ChipPAC Pte. Ltd.
392 patents
Oxford University Innovation Limited
391 patents
West Corporation
391 patents
Shenzhen Mindray Bio-medical Electronics Co., Ltd.
391 patents
Ademco Inc.
390 patents
Alliance for Sustainable Energy, LLC
390 patents
Allison Transmission, Inc.
390 patents
What this shows Shenzhen holds 391 patents at rank #1,089, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #1,089 in granted patent volume.
Other assignees with the most granted patents in Shenzhen's primary technology class.
Two PlainPatent-derived peer sets for Shenzhen, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (66 here).
Nearest assignees by average claims per patent (16.5 here).
Shenzhen's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
66 Top 1% higher than 99% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 38 | 9.7% |
| 2016 | 21 | 5.4% |
| 2017 | 26 | 6.6% |
| 2018 | 24 | 6.1% |
| 2019 | 22 | 5.6% |
| 2020 | 36 | 9.2% |
| 2021 | 37 | 9.5% |
| 2022 | 43 | 11.0% |
| 2023 | 53 | 13.6% |
| 2024 | 58 | 14.8% |
| 2025partial year | 33 | 8.4% |
Top 15 of 73 technology areas
Overall rank by patents
#1,089
of 49,997 tracked assignees
66.3 out of 100
What to do with this data
Shenzhen Mindray Bio-medical Electronics Co., Ltd.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.